ClinicalTrials.Veeva

Menu

Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors. (PROM-1)

S

San Donato Group (GSD)

Status

Enrolling

Conditions

Thoracic Aortic Aneurysm (TAA)

Treatments

Other: Journey to diagnosis
Other: Awareness and self-esteem, acceptance of the condition
Other: Quality of life, functional health and well-being
Other: psychological and physical well-being

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this observational study is to define the behavioural and cardiovascular risk factor profiles of patients with genetic aortopathies. The main questions it aims to answer are:

  • How do the interconnections between lifestyle, stress, psychological condition, perception of illness, and state of health influence each other in this population?
  • Beyond traditional risk factors, additional emerging factors should be considered, including pregnancy-related complications, sedentary lifestyle, early menopause and depression. The interplay between eating disorders, lifestyle factors and autoimmune or inflammatory bowel diseases remains poorly understood.

Full description

Thoracic aortic aneurysms (TAA) present peculiar symptoms as well as high mortality due to complications related to dilatation and dissection of the ascending aorta and great arteries. The presence or absence of extra-aortic features determines whether TAADs are syndromic, associated with diseases affecting other systems and organs, or non-syndromic, with manifestations limited to the aorta. Life expectancy of patients withTAA has improved markedly in the last decades, but still remains lower than that of the general population.

Enrollment

208 estimated patients

Sex

All

Ages

14 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • signed onformed consent
  • Ability to speak, read and write in Italian

Exclusion criteria

-

Trial design

208 participants in 1 patient group

TAA
Description:
subjects with TAA aged between 14 and 60 years
Treatment:
Other: psychological and physical well-being
Other: Awareness and self-esteem, acceptance of the condition
Other: Quality of life, functional health and well-being
Other: Journey to diagnosis

Trial contacts and locations

1

Loading...

Central trial contact

Alessandro Pini, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems